Angeles Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,095
Closed -$546K 44
2024
Q4
$546K Sell
2,095
-102
-5% -$30.3K 0.03% 82
2024
Q3
$708K Sell
2,197
-135
-6% -$44.2K 0.04% 62
2024
Q2
$729K Sell
2,332
-259
-10% -$76.1K 0.04% 59
2024
Q1
$737K Buy
2,591
+99
+4% +$29K 0.04% 67
2023
Q4
$718K Buy
2,492
+50
+2% +$13.6K 0.04% 57
2023
Q3
$656K Buy
+2,442
New +$609K 0.05% 52
2023
Q2
Sell
-875
Closed -$212K 163
2023
Q1
$212K Buy
+875
New +$215K 0.02% 145

Other funds holding AMGN

Angeles Investment Advisors's AMGN Position: Q1 2025 in Review

Angeles Investment Advisors sold out of Amgen (AMGN) in Q1 2025, closing a stake of 2,095 shares — an estimated $546K sold.

Angeles Investment Advisors first reported a position in AMGN in Q1 2023 and held it in 7 quarters. The position peaked at $737K in Q1 2024. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Angeles Investment Advisors reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Angeles Investment Advisors sold 2,095 Amgen shares in Q1 2025, an estimated $546K.
  • Angeles Investment Advisors first reported a position in Amgen in Q1 2023 and held it in 7 quarters.
  • Angeles Investment Advisors's Amgen position peaked at $737K in Q1 2024.
  • 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Angeles Investment Advisors's 13F filing for Q1 2025, filed 15 May 2025.